|
Hematologic Malignancy Grand Rounds - FY18 Smoldering Multiple Myeloma Treat or Not to Treat Who Won the Debate |
04/20/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 |
04/13/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 9100 Questions: The True Value of Yellow Gowns? Miracle or Myth: Claritin and Neulasta |
04/06/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 When standard treatment for rare disease fails- what next |
03/30/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Microparticles and Cancer |
03/23/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 The Dilemma of CTCL |
03/16/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Genomic diagnosis and treatment of lymphomas: From single cells to many humans |
03/09/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds Extramedullary Disease in AML Does it Matter |
03/02/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 The Curious Case of the Vanishing Neoplasm |
02/23/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 The LAST Study: Life After Stopping TKI’s |
02/16/2018 - 9:00am to 10:00am EST |
Facebook
Twitter
LinkedIn
Forward